» Articles » PMID: 39741275

Insights into the Roles of Exogenous Phenylalanine and Tyrosine in Improving Rapamycin Production of Streptomyces Rapamycinicus with Transcriptome Analysis

Overview
Publisher Biomed Central
Date 2024 Dec 31
PMID 39741275
Authors
Affiliations
Soon will be listed here.
Abstract

Rapamycin is an important natural macrolide antibiotic with antifungal, immunosuppressive and antitumor activities produced by Streptomyces rapamycinicus. However, their prospective applications are limited by low fermentation units. In this study, we found that the exogenous aromatic amino acids phenylalanine and tyrosine could effectively increase the yield of rapamycin in industrial microbial fermentation. To gain insight into the mechanism of rapamycin overproduction, comparative transcriptomic profiling was performed between media with and without phenylalanine and tyrosine addition. The results showed that the addition of phenylalanine and tyrosine upregulated the transcription levels of genes involved in rapamycin biosynthesis, precursor production, and transporters. In addition, the transcription levels of many carbohydrate metabolism-related genes were down-regulated, leading to a decrease in growth, suggesting that balancing cell growth and rapamycin biosynthesis may be important to promote efficient biosynthesis of rapamycin in Streptomyces rapamycinicus. These results provide a basis for understanding physiological roles of phenylalanine and tyrosine, and a new way to increase rapamycin production in Streptomyces cultures.

References
1.
Sattely E, Fischbach M, Walsh C . Total biosynthesis: in vitro reconstitution of polyketide and nonribosomal peptide pathways. Nat Prod Rep. 2008; 25(4):757-93. DOI: 10.1039/b801747f. View

2.
Jung W, Yoo Y, Park J, Park S, Han A, Ban Y . A combined approach of classical mutagenesis and rational metabolic engineering improves rapamycin biosynthesis and provides insights into methylmalonyl-CoA precursor supply pathway in Streptomyces hygroscopicus ATCC 29253. Appl Microbiol Biotechnol. 2011; 91(5):1389-97. DOI: 10.1007/s00253-011-3348-6. View

3.
Weber T, Abendroth D, Schelzig H . Rapamycin rescue therapy in patients after kidney transplantation: first clinical experience. Transpl Int. 2005; 18(2):151-6. DOI: 10.1111/j.1432-2277.2004.00032.x. View

4.
Park S, Yoo Y, Ban Y, Yoon Y . Biosynthesis of rapamycin and its regulation: past achievements and recent progress. J Antibiot (Tokyo). 2010; 63(8):434-41. DOI: 10.1038/ja.2010.71. View

5.
Zhu X, Zhang W, Chen X, Wu H, Duan Y, Xu Z . Generation of high rapamycin producing strain via rational metabolic pathway-based mutagenesis and further titer improvement with fed-batch bioprocess optimization. Biotechnol Bioeng. 2010; 107(3):506-15. DOI: 10.1002/bit.22819. View